MAPT and Alzheimer disease: Altogether, our data suggest that serotonergic denervation may increase tau hyperphosphorylation in denervated areas, and synergistically contribute to learning and memory impairment, as observed in AD, supporting the idea that therapeutic approaches could target specific neurotransmitter systems.